Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

Antiphospholipid antibodies (aPL) are mandatory for the diagnosis but are also a risk factor
for the antiphospholipid syndrome (APS) clinical manifestations. Lupus anticoagulant (LA) …

Background High incidence of thrombosis in COVID‐19 patients indicates a
hypercoagulable state. Hence, exploring the involvement of antiphospholipid antibodies …

Background Diagnosis of antiphospholipid syndrome (APS) requires persistent presence of
lupus anticoagulant (LAC), anticardiolipin (aCL) IgG/IgM, or anti‐β2 glycoprotein I (aβ2GPI) …

Background Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by
the presence of antiphospholipid antibodies (aPLs) and thrombotic events. The association …

The diagnosis of antiphospholipid syndrome (APS) relies on the detection of
antiphospholipid antibodies (aPL). Currently, lupus anticoagulant (LA), anticardiolipin (aCL) …

Antiphospholipid syndrome (APS) is an autoimmune prothrombotic disease characterized
by thrombosis and/or pregnancy complications caused by antiphospholipid antibodies …

Abstract Purpose of the Review This review focuses on the laboratory tests necessary for the
diagnosis of antiphospholipid syndrome (APS). For the interpretation of the results of the …

Classification criteria for antiphospholipid syndrome (APS) require IgG or IgM isotypes of the
anticardiolipin (aCL) antibodies, anti-β2 glycoprotein I (anti-β2GPI) antibodies, and/or the …

Antiphospholipid syndrome (APS) is a systemic autoimmune condition characterised by the
presence of antiphospholipid antibodies (aPL) associated with vascular thrombosis and/or …